Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMS vs TAU for First-Episode Depression
NCT06644833Phase 4Not yet recruiting
- Sponsor
- Sultan Qaboos University
- Start
- Jan 2025
- Primary completion
- Dec 2028
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Sultan Qaboos University. Primary endpoints: Remission Rate at 6 weeks and Response Rate at 6 weeks. Planned start Jan 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06644833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06644833.